Stratos Wealth Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $423K | Buy |
6,740
+614
| +10% | +$42.8K | ﹤0.01% | 1134 |
|
|
2025
Q4 | $407K | Buy |
6,126
+2,632
| +75% | +$170K | ﹤0.01% | 1132 |
|
|
2025
Q3 | $235K | Buy |
3,494
+676
| +24% | +$53.5K | ﹤0.01% | 1376 |
|
|
2025
Q2 | $246K | Sell |
2,818
-610
| -18% | -$47.8K | ﹤0.01% | 1226 |
|
|
2025
Q1 | $234K | Buy |
3,428
+845
| +33% | +$69K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $201K | Buy |
+2,583
| New | +$191K | ﹤0.01% | 1354 |
|
|
2024
Q3 | – | Sell |
-2,675
| Closed | -$303K | – | 1463 |
|
|
2024
Q2 | $303K | Sell |
2,675
-43
| -2% | -$5.44K | ﹤0.01% | 1085 |
|
|
2024
Q1 | $377K | Buy |
2,718
+42
| +2% | +$5.28K | 0.01% | 1003 |
|
|
2023
Q4 | $332K | Sell |
2,676
-286
| -10% | -$29.2K | 0.01% | 1033 |
|
|
2023
Q3 | $276K | Buy |
2,962
+318
| +12% | +$35.8K | 0.01% | 1052 |
|
|
2023
Q2 | $340K | Sell |
2,644
-907
| -26% | -$110K | 0.01% | 907 |
|
|
2023
Q1 | $413K | Sell |
3,551
-2,005
| -36% | -$224K | 0.01% | 759 |
|
|
2022
Q4 | $629K | Sell |
5,556
-366
| -6% | -$40.2K | 0.02% | 646 |
|
|
2022
Q3 | $477K | Sell |
5,922
-125
| -2% | -$10.6K | 0.01% | 705 |
|
|
2022
Q2 | $451K | Buy |
6,047
+371
| +7% | +$33.9K | 0.01% | 767 |
|
|
2022
Q1 | $726K | Buy |
5,676
+1,360
| +32% | +$149K | 0.02% | 659 |
|
|
2021
Q4 | $579K | Buy |
4,316
+20
| +0.5% | +$2.87K | 0.01% | 759 |
|
|
2021
Q3 | $587K | Buy |
4,296
+76
| +2% | +$9.58K | 0.01% | 695 |
|
|
2021
Q2 | $450K | Buy |
4,220
+268
| +7% | +$25.7K | 0.01% | 806 |
|
|
2021
Q1 | $355K | Buy |
3,952
+20
| +0.5% | +$1.88K | 0.01% | 828 |
|
|
2020
Q4 | $363K | Sell |
3,932
-596
| -13% | -$53.2K | 0.01% | 779 |
|
|
2020
Q3 | $467K | Buy |
4,528
+396
| +10% | +$41.4K | 0.02% | 644 |
|
|
2020
Q2 | $419K | Buy |
4,132
+204
| +5% | +$18.2K | 0.01% | 659 |
|
|
2020
Q1 | $264K | Buy |
3,928
+196
| +5% | +$12.2K | 0.01% | 726 |
|
|
2019
Q4 | $204K | Buy |
+3,732
| New | +$177K | 0.01% | 910 |
|
|
2018
Q4 | – | Sell |
-3,476
| Closed | -$124K | – | 1231 |
|
|
2018
Q3 | $124K | Buy |
+3,476
| New | +$108K | 0.01% | 1033 |
|
|
2018
Q2 | – | Sell |
-4,476
| Closed | -$83K | – | 1368 |
|
|
2018
Q1 | $83K | Sell |
4,476
-788
| -15% | -$11.7K | ﹤0.01% | 1295 |
|
|
2017
Q4 | $76K | Buy |
+5,264
| New | +$68.4K | ﹤0.01% | 1313 |
|
Other funds holding DXCM
VCM
VPM
Stratos Wealth Partners's DXCM Position: Q1 2026 in Review
Stratos Wealth Partners increased its DexCom (DXCM) stake by 10% in Q1 2026, buying an estimated $42.8K and bringing the position to 6,740 shares worth $423K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.
Stratos Wealth Partners first reported a position in DXCM in Q4 2017 and has held it in 28 quarters since. The position peaked at $726K in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Stratos Wealth Partners held 6,740 shares of DexCom worth $423K as of Q1 2026.
- Stratos Wealth Partners bought 614 DexCom shares in Q1 2026, an estimated $42.8K.
- DexCom made up ﹤0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #1134 holding.
- Stratos Wealth Partners first reported a position in DexCom in Q4 2017 and has held it in 28 quarters since.
- Stratos Wealth Partners's DexCom position peaked at $726K in Q1 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.